MyJournals Home  

RSS FeedsCombination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma (Bone Marrow Transplantation)

 
 

5 may 2018 12:00:03

 
Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma (Bone Marrow Transplantation)
 




 
139 viewsCategory: Medicine, Pathology
 
Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant (Bone Marrow Transplantation)
Hematopoietic stem cell transplantation for adult sickle cell disease in the era of universal donor availibility (Bone Marrow Transplantation)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pathology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten